Calliditas Therapeutics AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Calliditas Therapeutics AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011796
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Calliditas Therapeutics AB (Calliditas), formerly, Pharmalink AB is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; and Busulipo which is under Phase II clinical trials. Its pipeline product also includes Xepol XP-28, which is used for the treatment of post-polio syndrome and is under pre-license sales.Calliditas also partners with medical research institutions including the Karolinska Institute and Uppsala University. Calliditas is headquartered in Stockholm, Sweden.

Calliditas Therapeutics AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Calliditas Therapeutics AB, Medical Devices Deals, 2011 to YTD 2017 9
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Pharmalink Acquires Anti-Inflammatory Drug from Synartro 11
Venture Financing 12
Pharmalink Raises USD12 Million in Financing 12
Pharmalink Raises US$15 Million In Series C Financing 13
Pharmalink Secures US$5.1 Million In Series B Financing 15
Partnerships 16
Archimedes Pharma Enters Into Licensing Agreement With Pharmalink 16
Equity Offering 17
Pharmalink Plans IPO 17
Calliditas Therapeutics AB – Key Competitors 18
Calliditas Therapeutics AB – Key Employees 19
Calliditas Therapeutics AB – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Aug 24, 2017: Thomas Eklund New Chairman of Pharmalink 21
Aug 15, 2017: Pharmalink strengthens its management team. Appoints new Chief Financial Officer and head of communications 22
Jan 09, 2017: Pharmalink strengthens board with appointment of Maria Carell as Chair 23
Nov 30, 2016: Sweden’s Pharmalink obtains OMP designation for Nefecon 24
Other Significant Developments 25
Nov 15, 2017: Pharmalink is renamed Calliditas Therapeutics 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Key Facts 2
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Calliditas Therapeutics AB, Deals By Therapy Area, 2011 to YTD 2017 8
Calliditas Therapeutics AB, Medical Devices Deals, 2011 to YTD 2017 9
Calliditas Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pharmalink Acquires Anti-Inflammatory Drug from Synartro 11
Pharmalink Raises USD12 Million in Financing 12
Pharmalink Raises US$15 Million In Series C Financing 13
Pharmalink Secures US$5.1 Million In Series B Financing 15
Archimedes Pharma Enters Into Licensing Agreement With Pharmalink 16
Pharmalink Plans IPO 17
Calliditas Therapeutics AB, Key Competitors 18
Calliditas Therapeutics AB, Key Employees 19

★海外企業調査レポート[Calliditas Therapeutics AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emami Limited:戦略・SWOT・企業財務分析
    Emami Limited - Strategy, SWOT and Corporate Finance Report Summary Emami Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tupperware Brands Corp (TUP):企業の財務・戦略的SWOT分析
    Tupperware Brands Corp (TUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ViroGates AS (VIRO):医療機器:M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • Co-Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • CorVel Corporation (CRVL):企業財務及び戦略的SWOT分析
    Summary CorVel Corporation (CorVel) is a risk management solution provider that offers technology services. The company provides communication and information technology to improve healthcare management for workers’ compensation, group health, auto and liability claims management. It offers service, …
  • Quality Systems Inc (QSII)-医療機器分野:企業M&A・提携分析
    Summary Quality Systems Inc (QSI) is a healthcare technology company that develops and markets practice management and electronic health records solutions. The company’s solutions comprise ambulatory solutions, population health management and analytics, RCM services, NextGen consulting services, in …
  • Bank of the Ryukyus, Ltd.:企業の戦略・SWOT・財務情報
    Bank of the Ryukyus, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of the Ryukyus, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • China CNR Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China CNR Corporation Limited M …
  • Difference Capital Financial Inc.:企業のM&A・提携・投資分析
    Difference Capital Financial Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Difference Capital Financial Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Emlin Cosmetics :企業の戦略・SWOT・財務分析
    SummaryEmlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Investec Private Bank (UK & Europe):企業の戦略・SWOT・財務情報
    Investec Private Bank (UK & Europe) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (UK & Europe) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Electricite de France SA (EDF)-エネルギー分野:企業M&A・提携分析
    Summary Electricite de France S.A. (EDF) is a state-owned integrated energy company that generates, transmits, distributes and sells electricity; supplies natural gas; and offers energy services such as district heating, thermal energy services and other services. The group generates electricity fro …
  • Semco Maritime AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Semco Maritime AS (Semco Maritime) is a project engineering company that provides design, fabrication, service and maintenance for energy projects. The company’s products include cables, glands and support systems, reducers, adaptors and blind plugs, junction boxes, signalling equipment, lig …
  • ageas SA/NV:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ageas SA/NV Mergers and Acquisi …
  • City of Hope-製薬・医療分野:企業M&A・提携分析
    Summary City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation servic …
  • The Maryborough Sugar Factory Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Maryborough Sugar Factory L …
  • Sequenom, Inc. (SQNM):企業のM&A・提携動向(医療機器分野)
    Summary Sequenom, Inc. (Sequenom) is a life sciences company. It carries out the development and manufacture of DNA analysis systems and related consumables and reagent kits for fine mapping genotyping applications, biomedical research, agricultural applications, molecular medicine and non-invasive …
  • GlaxoSmithKline Pharmaceuticals Ltd (GLAXO):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft in Munchen:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Munchener Ruckversicherungs-Ges …
  • Arcan Resources Ltd. (ARN):企業概要、財務及び戦略的SWOT分析
    Summary Arcan Resources Ltd. (Arcan) is an oil and gas company. The company produces, develops, explores and acquires natural gas and oil. It explores and produces light, sweet oil from the Western Canadian Sedimentary Basin. Arcan operations include Swan Hills Complex and Waterflood operations. The …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆